<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056766</url>
  </required_header>
  <id_info>
    <org_study_id>00002</org_study_id>
    <nct_id>NCT05056766</nct_id>
  </id_info>
  <brief_title>How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement</brief_title>
  <acronym>OAMMM</acronym>
  <official_title>How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolve According to Propulsion: Control With Each mm of Advancement&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de Valence</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier de Valence</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The OAMMM study is a mono-centrer , non interventional, prospective study, carried out in CH&#xD;
      Valence&#xD;
&#xD;
      Oral Appliance is indicated for first line moderate sleep Apnea Syndrome or severe sleep&#xD;
      Apnea Syndrome after failure of positive airway pressure (CPAP).&#xD;
&#xD;
      Clinical impact of each mm advancement of Oral Appliance is imperfectly assessed.&#xD;
&#xD;
      The study aim to assess clinical and paraclinical efficacy of an oral Appliance on each mm of&#xD;
      advancement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oral appliance will be delivered with a propulsion at 50% of the maximum advance and the&#xD;
      investigator will titrate the advance according to the usual method&#xD;
&#xD;
      Polygraphy and clinical effectiveness of the Oral appliance will be evaluate&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>apnea-hypopnea index</measure>
    <time_frame>6 months</time_frame>
    <description>severity of sleep apnea</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale score</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pichot fatigue questionnaire</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Respiratory Tract Diseases</condition>
  <arm_group>
    <arm_group_label>single group assignement</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>questionnaires: Epworth Sleepiness Scale; Pichot fatigue questionnaire.</intervention_name>
    <description>Each patient will undergo 3 to 7 polygraphy recordings according usual practice of titration At the same time, Self-questionnaires will be conducted by the patient in order to evaluate Oral appliance efficacy.&#xD;
Optimal titration of oral appliance will be done according subjectives parameters. (sleepeness Reduction and fatigue Reduction).&#xD;
Neither the investigator nor the patient will know the polygraphy results (apnea-hypopnea index)</description>
    <arm_group_label>single group assignement</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients, with primary Moderate sleep apnea or Severe sleep apnea with failure&#xD;
        continuous positive airway pressure( CPAP).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years old&#xD;
&#xD;
          -  Moderate sleep apnea diagnosis with clinical signs&#xD;
&#xD;
          -  Severe sleep apnea with failure continuous positive airway pressure( CPAP)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous sleep apnea treatment for Moderate sleep apnea&#xD;
&#xD;
          -  refusal to participate in research&#xD;
&#xD;
          -  Patient under guardianship, deprived of liberty, safeguard of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume BUIRET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH VALENCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillaume BUIRET, MD</last_name>
    <phone>+33475818870</phone>
    <email>gbuiret@ch-valence.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandrine Beauchard, Msc</last_name>
    <phone>+33475818870</phone>
    <email>sbeauchard@ch-valence.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Valence</name>
      <address>
        <city>Valence</city>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Buiret, MD</last_name>
      <phone>+475757528</phone>
      <email>gbuiret@ch-valence.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sandrine Beauchard</last_name>
      <email>sbeauchard@ch-valence.fr</email>
    </contact_backup>
    <investigator>
      <last_name>guillaume buiret, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral appliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

